Unichem Laboratories Limited (BOM:506690)
550.20
-3.70 (-0.67%)
At close: Sep 25, 2026
Unichem Laboratories Market Cap
Unichem Laboratories has a market cap or net worth of 38.74 billion as of September 25, 2026. Its market cap has increased by 12.15% in one year.
Market Cap
38.74B
Enterprise Value
40.84B
Revenue
23.08B
Ranking
n/a
PE Ratio
12.74
Stock Price
550.20
ChartMarket Cap Chart
Since July 30, 2001, Unichem Laboratories's market cap has increased from 5.81B to 38.74B, an increase of 567.05%. That is a compound annual growth rate of 7.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 38.74B | 24.66% |
| Dec 31, 2025 | 31.07B | -40.43% |
| Dec 31, 2024 | 52.16B | 82.07% |
| Dec 29, 2023 | 28.65B | 28.87% |
| Dec 30, 2022 | 22.23B | 27.19% |
| Dec 31, 2021 | 17.48B | -5.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 75.38B |
| Sanofi India | 72.31B |
| Morepen Laboratories | 66.00B |
| FDC Limited | 55.53B |
| Novartis India | 48.43B |
| Gufic Biosciences | 42.41B |
| Kwality Pharmaceuticals | 38.10B |
| Hikal | 26.87B |